Chinese guideline for the diagnosis and treatment of Takayasu’s arteritis (2023)-Reference-Cited by-同舟云学术

Chinese guideline for the diagnosis and treatment of Takayasu’s arteritis (2023)

Published:2024-03-01 Issue:1 Volume:5 Page:5-26
ISSN:2719-4523
Container-title:Rheumatology and Immunology Research
language:en
Short-container-title:

Author:

Tian Xinping¹,Zeng Xiaofeng¹

Affiliation:

1. Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science& Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education , Beijing , China

Abstract

Abstract Takayasu’s arteritis (TAK) is a chronic granulomatous inflammatory disease that involves aorta and its primary branches. It is characterized by wall thickening, stenosis/obliteration or aneurysm formation of the involved arteries. In order to standardize the diagnosis and treatment of TAK in China, a clinical practice guideline with an evidence-based approach is developed under the leadership of National Clinical Medical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID). Eleven recommendations for 11 clinical questions that are important to the diagnosis and treatment of TAK are developed based on the latest evidence and expert opinions combined with real clinical practice in China.

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/rir-2024-0002/pdf

Reference122 articles.

1. Mason JC. Takayasu arteritis--advances in diagnosis and management. Nat Rev Rheumatol. 2010;6:406-415.

2. Chinese Medical Association Rheumatology Branch. Guidelines for the diagnosis and treatment of Takayasu arteritis (draft). Chin J Rheumatol. 2004;8:502–504.

3. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009;68:318–323.

4. Hellmich B, Agueda A, Monti S, et al. 2018 Update of the EU-LAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79:19–30.

5. Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Rheumatol. 2021;73:1349–1365.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Glimpse into Humoral Response and Related Therapeutic Approaches of Takayasu’s Arteritis;International Journal of Molecular Sciences;2024-06-13